Updates

Treatt - To exceed even recently upgraded forecasts

May 2017

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

Having said it was trading ahead of expectations in March, ingredient solutions firm Treatt now expects to beat even those upgraded numbers. Half year revenues are expected to show an increase in excess of 25%, with translation benefits from the strength of the US$ accounting for 10% of the growth and the rest due to higher volumes. New business wins and a strong performance have been seen across all categories, particularly in sugar reduction, tea and citrus lines, whilst the move towards added value is lifting margins. Before the news, brokers had been expecting £11.5m pretax profit/eps of 15.9p for the year to end September, with £12.2m/17p next year.Results are due on 9 May. A main Buy at 217.5p in November&rsqu ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

Innovaderma - All time record quarter

Satellite Solutions

Treatt (May 2023)

Treatt (September 2022)

Treatt - Explosive growth trajectory; gain 336% (March 2021)

Treatt - 95% gain since our main write up in November â€˜16 (February 2018)

Treatt - Trading substantially ahead of forecasts (March 2017)

Treatt - Sugar free flavourings take off (November 2016)

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X